# Sachem Capital Corp.: financial statements, quarterly

SACH · NYSE · CIK 1682220 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sach.md) · [Financials](/companies/sach/financials.md) · [Filings](/companies/sach/filings.md) · [Insiders](/companies/sach/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sach/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [17.8](/filings/0001410578-24-001965.md) | [16.4 d](/filings/0001410578-25-000587.md) | [16.8](/filings/0001410578-25-001059.md) | [15.1](/filings/0001682220-25-000044.md) | [14.8](/filings/0001682220-25-000070.md) | [10.8 d](/filings/0001410578-25-000587.md) | [11.4](/filings/0001410578-25-001059.md) | [10.8](/filings/0001682220-25-000044.md) | [12.0](/filings/0001682220-25-000070.md) | not reported | not reported | not reported |
| Operating income | $m | [6.4](/filings/0001410578-24-001965.md) | [(1.6) d](/filings/0001410578-25-000587.md) | [4.3](/filings/0001410578-25-001059.md) | [(3.1)](/filings/0001682220-25-000044.md) | [(4.8)](/filings/0001682220-25-000070.md) | [(14.1) d](/filings/0001410578-25-000587.md) | [1.0](/filings/0001410578-25-001059.md) | [1.1](/filings/0001682220-25-000044.md) | [(0.4)](/filings/0001682220-25-000070.md) | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001410578-24-001965.md) | [0.0 d](/filings/0001410578-25-000587.md) | [0.2](/filings/0001410578-25-001059.md) | [0.0](/filings/0001682220-25-000044.md) | [0.0](/filings/0001682220-25-000070.md) | [0.0 d](/filings/0001410578-25-000587.md) | [0.0](/filings/0001410578-25-001059.md) | [0.0](/filings/0001682220-25-000044.md) | [0.0](/filings/0001682220-25-000070.md) | [0.0 d](/filings/0001682220-26-000014.md) | not reported | not reported |
| Net income | $m | [6.2](/filings/0001410578-24-001965.md) | [(1.1) d](/filings/0001410578-25-000587.md) | [4.7](/filings/0001410578-25-001059.md) | [(3.1)](/filings/0001682220-25-000044.md) | [(5.1)](/filings/0001682220-25-000070.md) | [(36.1) d](/filings/0001682220-26-000014.md) | [0.9](/filings/0001682220-26-000038.md) | [1.9](/filings/0001682220-26-000053.md) | [1.0](/filings/0001682220-25-000070.md) | [2.5 d](/filings/0001682220-26-000014.md) | [(6.1)](/filings/0001682220-26-000038.md) | [(5.4)](/filings/0001682220-26-000053.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001410578-24-001965.md) | not reported | [0.08](/filings/0001410578-25-001059.md) | [(0.09)](/filings/0001682220-25-000044.md) | [(0.13)](/filings/0001682220-25-000070.md) | not reported | [0.00](/filings/0001682220-26-000038.md) | [0.02](/filings/0001682220-26-000053.md) | [0.00](/filings/0001682220-25-000070.md) | not reported | [(0.15)](/filings/0001682220-26-000038.md) | [(0.14)](/filings/0001682220-26-000053.md) |
| Basic EPS | $ per share | [0.12](/filings/0001410578-24-001965.md) | not reported | [0.08](/filings/0001410578-25-001059.md) | [(0.09)](/filings/0001682220-25-000044.md) | [(0.13)](/filings/0001682220-25-000070.md) | not reported | [0.00](/filings/0001682220-26-000038.md) | [0.02](/filings/0001682220-26-000053.md) | [0.00](/filings/0001682220-25-000070.md) | not reported | [(0.15)](/filings/0001682220-26-000038.md) | [(0.14)](/filings/0001682220-26-000053.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.8](/filings/0001410578-23-002412.md) | [12.6](/filings/0001410578-25-000587.md) | [18.4](/filings/0001410578-24-000719.md) | [10.6](/filings/0001410578-24-001401.md) | [5.9](/filings/0001410578-24-001965.md) | [18.1](/filings/0001682220-26-000014.md) | [24.4](/filings/0001410578-25-001059.md) | [22.5](/filings/0001682220-25-000044.md) | [11.2](/filings/0001682220-25-000070.md) | [10.9](/filings/0001682220-26-000053.md) | [11.6](/filings/0001682220-26-000038.md) | [28.8](/filings/0001682220-26-000053.md) |
| Total assets | $m | [638](/filings/0001410578-23-002412.md) | [621](/filings/0001410578-25-000587.md) | [627](/filings/0001410578-24-000719.md) | [586](/filings/0001410578-24-001401.md) | [555](/filings/0001410578-24-001965.md) | [492](/filings/0001682220-26-000014.md) | [491](/filings/0001410578-25-001059.md) | [502](/filings/0001682220-25-000044.md) | [484](/filings/0001682220-25-000070.md) | [460](/filings/0001682220-26-000053.md) | [473](/filings/0001682220-26-000038.md) | [473](/filings/0001682220-26-000053.md) |
| Total liabilities | $m | [402](/filings/0001410578-23-002412.md) | [391](/filings/0001410578-25-000587.md) | [389](/filings/0001410578-24-000719.md) | [356](/filings/0001410578-24-001401.md) | [335](/filings/0001410578-24-001965.md) | [310](/filings/0001682220-26-000014.md) | [312](/filings/0001410578-25-001059.md) | [324](/filings/0001682220-25-000044.md) | [309](/filings/0001682220-25-000070.md) | [285](/filings/0001682220-26-000053.md) | [308](/filings/0001682220-26-000038.md) | [314](/filings/0001682220-26-000053.md) |
| Long-term debt | $m | [288](/filings/0001410578-23-002412.md) | [288](/filings/0001410578-24-000381.md) | [288](/filings/0001410578-24-000719.md) | [265](/filings/0001410578-24-001401.md) | [265](/filings/0001410578-24-001965.md) | [230](/filings/0001410578-25-000587.md) | [230](/filings/0001410578-25-001059.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [236](/filings/0001410578-24-001965.md) | [230](/filings/0001682220-26-000014.md) | [237](/filings/0001682220-25-000044.md) | [230](/filings/0001682220-25-000070.md) | [221](/filings/0001682220-25-000070.md) | [182](/filings/0001682220-26-000053.md) | [179](/filings/0001682220-26-000053.md) | [178](/filings/0001682220-26-000053.md) | [176](/filings/0001682220-25-000070.md) | [175](/filings/0001682220-26-000053.md) | [166](/filings/0001682220-26-000053.md) | [159](/filings/0001682220-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [6,859 d](/filings/0001410578-24-001965.md) | [2,913 d](/filings/0001410578-25-000587.md) | [4,217](/filings/0001410578-25-001059.md) | [6,962 d](/filings/0001682220-25-000044.md) | [2,331 d](/filings/0001682220-25-000070.md) | [(620) d](/filings/0001682220-26-000014.md) | [191](/filings/0001682220-26-000038.md) | [501 d](/filings/0001682220-26-000053.md) | [4,932 d](/filings/0001682220-25-000070.md) | [(2,962) d](/filings/0001682220-26-000014.md) | [835](/filings/0001682220-26-000038.md) | [(3,588) d](/filings/0001682220-26-000053.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $k | [5,896 d](/filings/0001410578-24-001965.md) | [4,989 d](/filings/0001410578-25-000587.md) | [5,144](/filings/0001410578-25-001059.md) | [5,219 d](/filings/0001682220-25-000044.md) | [3,796 d](/filings/0001682220-25-000070.md) | [2,349 d](/filings/0001682220-26-000014.md) | [2,363](/filings/0001682220-26-000038.md) | [2,365 d](/filings/0001682220-26-000053.md) | [2,386 d](/filings/0001682220-25-000070.md) | [2,386 d](/filings/0001682220-26-000014.md) | [2,398](/filings/0001682220-26-000038.md) | [480 d](/filings/0001682220-26-000053.md) |
| Share repurchases | $k | [1.0 d](/filings/0001410578-24-001965.md) | [0.0 d](/filings/0001410578-25-000587.md) | not reported | not reported | not reported | [115 d](/filings/0001682220-26-000014.md) | not reported | not reported | not reported | [0.0 d](/filings/0001682220-26-000014.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.8](/filings/0001410578-23-002412.md) | [42.8](/filings/0001410578-24-000719.md) | [43.8](/filings/0001410578-24-001401.md) | [44.8](/filings/0001410578-24-001965.md) | [47.1](/filings/0001410578-25-001059.md) | [47.5](/filings/0001682220-25-000044.md) | [47.3](/filings/0001682220-25-000070.md) | [46.8](/filings/0001682220-26-000038.md) | [46.9](/filings/0001682220-26-000053.md) | [46.9](/filings/0001682220-25-000070.md) | [47.2](/filings/0001682220-26-000038.md) | [47.3](/filings/0001682220-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 47,954,632 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001682220-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.